Immuno Oncology Assay Market : Global Market Size and Forecast 2019-2025Posted by pranshu@95 on September 5th, 2019 Immuno Oncology Assay Market is growing rapidly owing to rising technological advancement across the globe. The immune system is an elegant and complex network which protects cells against an external threat such as parasites, viruses, and bacteria. Integrating the power of the immune system to combat cancer has been a fantasy of visionary scientists and physicians for more than a century. Until recently, however, countless efforts in the laboratory as well the clinic have been unsuccessful, with very few exceptions. Immune oncology is a unique approach that uses the body’s immune system to assist fight cancer. Immuno-oncology therapeutics is leading to a transformational shift in treatment paradigms for patients with cancer. A full report of the Immuno Oncology Assay Market is available at : https://www.omrglobal.com/industry-reports/immuno-oncology-assay-market Development of novel drugs, biologics, and devices will likely to lead to more effective therapies tailored to the unique immune biology within each cancer patient to stimulate and orchestrate the body’s natural defenses as a treatment for their cancer while minimizing toxicities. Immuno oncology assays is a next-generation sequencing application that provides real-time automated measurements of immune and tumor cells dynamics. With the help of this assay, biological processes driving the immune response against cancer which is significantly contributing to the immuno oncology assay market. Immune oncology assay helps in continuously monitoring and analyzing key event from proliferation and activation, to migration and immune cell killing without disturbing the existing body cells. This assay helps in maintaining cell health and morphology as well as offers real-time continuous analysis. Moreover, various types of immuno oncology assay include common immunotherapies which furthermore include Interleukins which are the naturally stirring protein that assists cells to communicate, immune response and regulating cell growth. Interferons are another type of cytokine which plays an important role in regulating many kinds of cell utilities. Interferons help the immune system to fight cancer by inhibiting cell division which can slow or stop the growth of cancer. Colony-stimulating factors strengthen the immune system and protect against infection by increasing the number of white blood cells produced in the bone marrow. The Immuno Oncology Therapeutics Program in the FDA Oncology Center of Excellence (OCE) serves to promote the development of new therapeutics that focus on harnessing the immune system to engage new, more efficacious treatment paradigms for patients with cancer. Such initiatives will bolster the immuno oncology assay market. The immuno oncology therapeutics program includes educational programs within the FDA to serve the training needs of staff to develop and to maintain expertise in the rapidly evolving field of immuno oncology and communication programs with stakeholders of immuno oncology therapeutics, including already approved products and novel products in development, to engage this community on the role of the OCE in furthering the development of immuno oncology therapeutics. Current Market Trends Covered in the Market Report:
Global Immuno Oncology Assay Market- Segmentation by Technology
by Cancer Type
by Application
Global Immuno Oncology Assay Market– Segment by Region
About Orion Market Research Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services. Media Contact: Like it? Share it! More by this author |